Differences in rates of glycation (glycation index) may significantly affect individual HbA(1c) results in type 1 diabetes

Annals of Clinical Biochemistry

Volumn 36, Issue 4, 1999, Pages 451-459

  Hudson, Peter R ^a   Child, David F ^a   Jones, Heather ^a   Williams, Clive P ^a  

^a WREXHAM MAELOR HOSPITAL   (United Kingdom)

Author keywords

Analysis of covariance; Diabetes monitoring; Inter individual differences; Post transcriptional glycation

Indexed keywords

FERRITIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATIENT MONITORING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0032775402     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329903600408     Document Type: Article

References (28)

1. 1 Gonen B, Robenstein AH, Rochman H, Tanega SP, Horwitz DL. Haemoglobin A1: an indicator of the metabolic control of diabetic patients. Lancet 1977; 2: 734-6
2. 1c, in diabetes mellitus. N Engl J Med 1976; 295: 417-20
3. 3 Goldstein DE, Little RR, Wiedmeyer HM, England JD, Rohlfing CL, Wilke A. Is glycohemoglobin testing useful in diabetes mellitus? Lessons from the diabetes control and complications trial. Clin Chem 1994; 40: 1637-40
4. 4 Philipu G, Phillips PJ. Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem 1993; 39: 2305-8
5. 5 Betke K, Marti HR, Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature 1959; 184: 1877-8
6. 6 Madsen H, Kjærgaard J-J, Ditzel J. Relationship between glycosylation of haemoglobin and the duration of diabetes: a study during the third trimester of pregnancy. Diabetologia 1982; 22: 37-40
7. 7 Frantzen F. Chromatographic and electrophoretic methods for modified hemoglobins. J Chromatog Biomed Appl 1997; 699: 269-86
8. 8 Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409-37
9. 9 Howey JEA, Bennet WM, Browning MCK, Jung RT, Fraser CG. Clinical utility of assays or glycosylated haemoglobin and serum fructosumine compared: use of data on biological variation. Diabetic Med 1989; 6: 793-6
10. 10 Harris EK. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974; 20: 1535-42
11. 11 American Diabetes Association. Clinical practice recommendations. Diabetes Care 1998; 21 (Suppl I): S69-71
12. 12 Cefalu WT, Wang ZQ, Bell-Farrow A, Kiger FD, Izlar C. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem 1994; 40: 1317-21
13. 13 Mortensen HB, Vølund Aa. Application of a biokinetic model for prediction and assessment of glycated haemoglobins in diabetic patients. Scand J Clin Lab Invest 1988; 48: 595-602
14. 14 Paisey RB, Macfarlane DG, Sherriff RJ, Hartog M, Slade RR, White DA. The relationship between blood glycated hemoglobin and home capillary blood glucose levels in diabetics. Diabetologia 1980; 19: 31-4
15. 15 Service FJ, O'Brien PC, Rizza RA. Measurements of glucose control. Diabetes Care 1987; 10: 225-37
16. 16 Svendsen PA, Lauritzen T, Soegaard U, Nerup J. Glycosylated hemoglobin and steady state mean blood glucose concentration in type 1 (insulin-dependent) diabetes. Diabetologia 1982; 23: 403-5
17. 17 Hollis S. Analysis of method comparison studies. Ann Clin Biochem 1996; 33: 1-4
18. 18 Service FJ. Correlation between glycemia and glycated hemoglobin. Compr Ther 1990; 16: 33-40
19. 19 Child DF, Wood J, Hudson PR, Williams CP, Roberts DR, Smith C. Multivariate analysis of glycosylated haemoglobin in insulin-treated diabetics. J Roy Soc Med 1985; 78: 549-51
20. 1c: relation to age, duration, C-peptide, insulin dose and one or two insulin injections. Diabetes Care 1982; 5: 399-403
21. 1c. Diabetes Care 1997; 20: 988-91
22. 22 Ceriello A, Quatraro A, Giugliano D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabetic Med 1992; 9: 297-9
23. 23 Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547-81
24. 24 Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davies S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 1990; 33: 208-15
25. 25 Gould BJ, Davie SJ, Yudkin JS. Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta 1997; 260: 49-64
26. 26 Cordera R, Andraghetti G, Bonadonna R, Gherzi R, Maielle M, Odetti P, et al. Influence of cell age and ketoaminic linkage on rapid glycation of hemoglobin in human red cells in vitro. Horm Metab Res 1985; 17: 201-4
27. 1c? An analysis of glycated hemoglobins by electrospray ionisation mass spectrometry. Clin Chem 1998; 44: 1951-8
28. 28 Roberts NB, Green BN, Morris M. Potential of electrospray mass spectrometry for quantifying glycohemoglobin. Clin Chem 1997; 43: 771-8